VideoRetinal Physician Video Channel Peter Kaiser, MD, and Chirag Jhaveri, MD, discuss gene therapy in wet AMD. April 17, 2024 The Retinal Physician Video Channel highlights developments and insights in retina science and patient care. Peter Kaiser, MD, and Chirag Jhaveri, MD, discuss gene therapy in wet AMD. Other Videos From Series Peter Kaiser, MD, and Aleksandra Rachitskaya, MD, discuss GLP-1 agonists Peter Kaiser, MD, and Danny Mammo, MD, discuss scleral windows Peter Kaiser, MD, and Diana Do, MD discuss selecting patients that would benefit from the port delivery system View More From Series Peter Kaiser, MD, and Lisa Faia, MD, discuss scleral fixated lenses and inflammation. Peter Kaiser, MD, and Ross Lakhanpal, MD, FACS, discuss new data related to treatment of geographic atrophy. Peter Kaiser, MD and Saradha Chexal, MD discuss patient selection for geographic atrophy treatments. Peter Kaiser, MD, and Dilsher Dhoot, MD, discuss incorporating medications into treatment for macular degeneration. Peter Kaiser, MD, and Priya Vakharia, MD, discuss the results from the GALE extension study. Peter Kaiser, MD, and Veeral Sheth, MD, MBA, FACS, FASRS, discuss reducing injection burden and gene therapy. Peter Kaiser, MD, and Arshad Khanani, MD, MA, FASRS, discuss new mechanisms of action in the management of retinal diseases. Peter Kaiser, MD, and Arshad Khanani, MD, MA, FASRS, discuss new mechanisms of action in the management of retinal diseases. Peter Kaiser, MD, and Yasha Modi, MD, discuss the impact of faricimab. Peter Kaiser, MD, and Sruthi Arepalli, MD, discuss the relationship of IL-6 to macular edema and eye inflammation Peter Kaiser, MD, and Christina Weng, MD, MBA, FASRS, discuss counseling patients on the variety of treatment options available Peter Kaiser, MD, and Dilsher Dhoot, MD, discuss treatment for macular degeneration. Peter Kaiser, MD, and Carl Regillo, MD, discuss the Port Delivery System Peter Kaiser, MD, and Joseph Coney, MD, FACS, discuss Dr. Coney's mission trips to Haiti and the impact international retinal physicians are having there. Peter Kaiser, MD, and María Berrocal, MD, discuss managing patients with Diabetic Macular Edema and proliferative disease with subhyaloid hemorrhage Peter Kaiser, MD, and Robert Avery, MD, discuss incorporating new drugs into your practice. Biosimilars for ranibizumab Peter Kaiser, MD Pediatric patients and gene therapy Peter Kaiser, MD and Nina Berrocal, MD Incorporating OCTA into your practice Peter Kaiser, MD and Jay Duker, MD Brolucizumab safety Peter Kaiser, MD and Arshad Khanani, MD Practice changes due to COVID-19 Peter Kaiser, MD & Christina Weng, MD New treatments for dry AMD Peter Kaiser, MD What’s new in pediatric retina Gene therapy for macular degeneration The utility of OCTA Brolucizumab to treat wet AMD The safety of brolucizumab Close out AMD Awareness Month New ways to treat nAMD patients Tie2 pathway and why it's important Unmet needs in macular degeneration Clinical trials and real world outcomes Highlighting key presentations from ASRS Challenges in achieving treatment goals Effects of missed anti-VEGF treatments New drug therapies for diabetic macular edema The use of steroids for the treatment of macular edema Using a suprachoroidal needle to inject triamcinolon Delivering triamcinolone to the suprachoroidal space Discuss the use of a newly approved needle combined with a steroid for injections
Peter Kaiser, MD, and Diana Do, MD discuss selecting patients that would benefit from the port delivery system
Peter Kaiser, MD, and Ross Lakhanpal, MD, FACS, discuss new data related to treatment of geographic atrophy.
Peter Kaiser, MD, and Dilsher Dhoot, MD, discuss incorporating medications into treatment for macular degeneration.
Peter Kaiser, MD, and Veeral Sheth, MD, MBA, FACS, FASRS, discuss reducing injection burden and gene therapy.
Peter Kaiser, MD, and Arshad Khanani, MD, MA, FASRS, discuss new mechanisms of action in the management of retinal diseases.
Peter Kaiser, MD, and Arshad Khanani, MD, MA, FASRS, discuss new mechanisms of action in the management of retinal diseases.
Peter Kaiser, MD, and Sruthi Arepalli, MD, discuss the relationship of IL-6 to macular edema and eye inflammation
Peter Kaiser, MD, and Christina Weng, MD, MBA, FASRS, discuss counseling patients on the variety of treatment options available
Peter Kaiser, MD, and Joseph Coney, MD, FACS, discuss Dr. Coney's mission trips to Haiti and the impact international retinal physicians are having there.
Peter Kaiser, MD, and María Berrocal, MD, discuss managing patients with Diabetic Macular Edema and proliferative disease with subhyaloid hemorrhage